Corpus 1,280 assessed · 1,181 scored · 646 reproduced ≥75 · 170 flagged ·∅ 74/100

Publications 2 Datasets 392.5k Experiments 5.2k

Explore

Filters: 1 ✕ 1 ✕ xenograft tumor model ✕ clear all

2 matching publication(s)

Publication	Journal	Year	Score	Verdict
The oncogene AAMDC links PI3K-AKT-mTOR signaling with metabolic reprograming in estrogen receptor-positive breast cancer. PMID 33772001	Nat Commun	2021	85	L1 85/100
Epigenome screening highlights that JMJD6 confers an epigenetic vulnerability and mediates sunitinib sensitivity in renal cell carcinoma. PMID 33634984	Clin Transl Med	2021	85	L1 85/100

The oncogene AAMDC links PI3K-AKT-mTOR signaling with metabolic reprograming in estrogen receptor-positive breast cancer.

PMID 33772001 · Nat Commun · 2021

L1 85/100

Epigenome screening highlights that JMJD6 confers an epigenetic vulnerability and mediates sunitinib sensitivity in renal cell carcinoma.

PMID 33634984 · Clin Transl Med · 2021

L1 85/100